









Mercado
/
Acciones
/
nasdaq-kvue
/

Kenvue Inc

KVUE

21.509USD

+0.059+0.28%

Horarios del mercado （ET）Cotizaciones retrasadas 15 min

41.27BCap. mercado

40.07P/E TTM



Kenvue Inc

21.509

+0.059+0.28%

Kenvue Inc. is a consumer health company. The Company’s differentiated portfolio of brands includes Tylenol, Neutrogena, Listerine, Johnson’s, BAND-AID, Aveeno, Zyrtec, and Nicorette. It operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. Its Self Care product categories include pain care; cough, cold, and allergy; digestive health; smoking cessation; eye care; and other products. Self Care segments include brands such as Tylenol, Motrin, Nicorette, Benadryl, Zyrtec, Zarbee’s, ORSLTM, Rhinocort, and Calpol. The Skin Health and Beauty segment is focused on face and body care, as well as hair, sun, and other products. The Essential Health segment includes oral care, baby care, women’s health, wound care, and other products. Its portfolio includes Self Care, Skin Health and Beauty, and Essential Health products which connect with consumers across North America, Asia Pacific (APAC), Europe, Middle East, and Africa (EMEA), and Latin America (LATAM).

Información de la empresa

Símbolo de cotizaciónKVUE

Nombre de la empresaKenvue Inc

Fecha de salida a bolsaMay 04, 2023

Fundada en2022

Director ejecutivoMr. Thibaut Mongon

Número de empleados22000

Tipo de seguridadOrdinary Share

Fin del año fiscalMay 04

Dirección1 Kenvue Way

CiudadSUMMIT

Bolsa de valoresNYSE Consolidated

PaísUnited States of America

Código postal07901

Teléfono19088741200

Sitio Webhttps://www.kenvue.com

Símbolo de cotizaciónKVUE

Fecha de salida a bolsaMay 04, 2023

Fundada en2022

Ejecutivos de la empresa

Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Mr. Thibaut Mongon

Chief Executive Officer, Director

216.47K

+8.04%

Ms. Meredith (Meri) Stevens

Chief Operations Officer

64.44K

+5.82%

Mr. Carlton Lawson

Group President, Europe, Middle East and Africa and Latin America

56.32K

-14.66%

Ms. Bing (Ellie) Xie

Group President, Asia Pacific

47.60K

+8.84%

Dr. Caroline Tillett

Chief Scientific Officer

44.13K

+6.62%

Mr. Jan Meurer

Group President, North America

33.18K

+15.35%

Ms. Luani Alvarado

Chief People Officer

31.36K

+9.72%

Ms. Charmaine England

Chief Growth Officer

29.06K

+5.68%

Mr. Michael E. Sneed

Independent Director

28.44K

+52.59%

Mr. Larry J. Merlo

Independent Chairman of the Board

27.46K

+124.86%

Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Mr. Thibaut Mongon

Chief Executive Officer, Director

216.47K

+8.04%

Ms. Meredith (Meri) Stevens

Chief Operations Officer

64.44K

+5.82%

Mr. Carlton Lawson

Group President, Europe, Middle East and Africa and Latin America

56.32K

-14.66%

Ms. Bing (Ellie) Xie

Group President, Asia Pacific

47.60K

+8.84%

Dr. Caroline Tillett

Chief Scientific Officer

44.13K

+6.62%

Mr. Jan Meurer

Group President, North America

33.18K

+15.35%

Desglose de ingresos

Divisa: USDActualizado: dom., 6 de abr

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2021

FY2020

FY2019

Por negocioUSD

Nombre

Ganancia

Proporción

Face and Body Care

2.94B

19.00%

Other Self Care

2.32B

15.00%

Cough, Cold and Allergy

2.16B

14.00%

Pain Care

2.01B

13.00%

Other Essential Health

1.70B

11.00%

Other

4.33B

28.00%

Por regiónUSD

Nombre

Ganancia

Proporción

Northern America

7.58B

49.04%

Europe, Middle East, and Africa

3.56B

23.03%

Asia - Pacific

2.97B

19.24%

Latin America

1.34B

8.69%

Por negocio

Por región

Por negocioUSD

Nombre

Ganancia

Proporción

Face and Body Care

2.94B

19.00%

Other Self Care

2.32B

15.00%

Cough, Cold and Allergy

2.16B

14.00%

Pain Care

2.01B

13.00%

Other Essential Health

1.70B

11.00%

Other

4.33B

28.00%

Estadísticas de accionistas

Actualizado: vie., 16 de may

Accionistas

Tipos de accionistas

Accionistas

Proporción

The Vanguard Group, Inc.

11.89%

T. Rowe Price Associates, Inc.

10.85%

State Street Global Advisors (US)

6.26%

BlackRock Institutional Trust Company, N.A.

4.91%

MFS Investment Management

4.85%

Other

61.23%

Accionistas

Proporción

The Vanguard Group, Inc.

11.89%

T. Rowe Price Associates, Inc.

10.85%

State Street Global Advisors (US)

6.26%

BlackRock Institutional Trust Company, N.A.

4.91%

MFS Investment Management

4.85%

Other

61.23%

Tipos de accionistas

Accionistas

Proporción

Investment Advisor/Hedge Fund

44.75%

Investment Advisor

44.35%

Hedge Fund

4.36%

Research Firm

3.22%

Pension Fund

1.71%

Sovereign Wealth Fund

1.40%

Bank and Trust

1.18%

Family Office

0.19%

Family Office

0.19%

Participación institucional

Actualizado: dom., 19 de ene

Periodo del informe

Número de instituciones

Acciones mantenidas

Proporción

Cambio

2025Q1

2016

1.96B

102.26%

-286.97M

2024Q4

1944

1.96B

102.60%

-253.31M

2024Q3

1828

1.91B

99.61%

-331.64M

2024Q2

1723

1.90B

99.19%

-79.08M

2024Q1

1598

1.90B

99.47%

-51.94M

2023Q4

1442

1.89B

98.66%

-22.82M

2023Q3

1206

1.90B

99.22%

-343.08M

2023Q2

232

1.95B

101.85%

+1.90B

2023Q1

0.00%

-14.23K

2022Q4

0.00%

-14.23K

Actividad de los accionistas

Nombre

Acciones mantenidas

Proporción

Cambio

Cambio %

Fecha

The Vanguard Group, Inc.

217.71M

11.39%

+1.67M

+0.77%

Dec 31, 2024

T. Rowe Price Associates, Inc.

242.05M

12.66%

+8.03M

+3.43%

Dec 31, 2024

State Street Global Advisors (US)

120.40M

6.3%

-6.81M

-5.36%

Dec 31, 2024

BlackRock Institutional Trust Company, N.A.

93.06M

4.87%

+2.22M

+2.44%

Dec 31, 2024

MFS Investment Management

93.86M

4.91%

+10.11M

+12.07%

Dec 31, 2024

Fidelity Management & Research Company LLC

106.19M

5.56%

-9.01M

-7.82%

Dec 31, 2024

Wellington Management Company, LLP

68.36M

3.58%

-10.72M

-13.56%

Dec 31, 2024

Geode Capital Management, L.L.C.

46.07M

2.41%

+1.39M

+3.12%

Dec 31, 2024

Harris Associates L.P.

31.52M

1.65%

+58.77K

+0.19%

Dec 31, 2024

Charles Schwab Investment Management, Inc.

24.97M

1.31%

+561.57K

+2.30%

Dec 31, 2024

ETFs relacionados

Actualizado: vie., 6 de jun

Nombre

Proporción

Renaissance IPO ETF

10.35%

First Trust US Equity Opportunities ETF

3.72%

Cullen Enhanced Equity Income ETF

3.7%

Brookstone Value Stock ETF

3.69%

TBG Dividend Focus ETF

3.63%

TrueShares Low Volatility Equity Income ETF

3.38%

First Trust Dorsey Wright Momentum & Dividend ETF

2.83%

Consumer Staples Select Sector SPDR Fund

2.8%

ProShares Ultra Consumer Staples

2.75%

Invesco S&P 500 Equal Weight Consumer Staples ETF

2.65%

Renaissance IPO ETF

Proporción10.35%

First Trust US Equity Opportunities ETF

Proporción3.72%

Cullen Enhanced Equity Income ETF

Proporción3.7%

Brookstone Value Stock ETF

Proporción3.69%

TBG Dividend Focus ETF

Proporción3.63%

TrueShares Low Volatility Equity Income ETF

Proporción3.38%

First Trust Dorsey Wright Momentum & Dividend ETF

Proporción2.83%

Consumer Staples Select Sector SPDR Fund

Proporción2.8%

ProShares Ultra Consumer Staples

Proporción2.75%

Invesco S&P 500 Equal Weight Consumer Staples ETF

Proporción2.65%

Dividendos

Un total de 2.32B USD se ha distribuido en dividendos durante los últimos 5 años.

Fecha

Dividendos

Fecha de registro

Fecha de pago

Fecha ex-dividendo

Jan 16, 2025

KVUE.NB Interim Cash Dividend of gross USD 0.205 paid on Feb 26, 2025 going ex on Feb 12, 2025

Feb 12, 2025

Feb 26, 2025

Feb 12, 2025

Oct 17, 2024

KVUE.NB Final Cash Dividend of gross USD 0.205 paid on Nov 27, 2024 going ex on Nov 13, 2024

Nov 13, 2024

Nov 27, 2024

Nov 13, 2024

Jul 25, 2024

KVUE.NB Interim Cash Dividend of gross USD 0.205 paid on Aug 28, 2024 going ex on Aug 14, 2024

Aug 14, 2024

Aug 28, 2024

Aug 14, 2024

Apr 25, 2024

KVUE.NB Interim Cash Dividend of gross USD 0.2 paid on May 22, 2024 going ex on May 07, 2024

May 08, 2024

May 22, 2024

May 07, 2024

Jan 25, 2024

KVUE.NB Interim Cash Dividend of gross USD 0.2 paid on Feb 28, 2024 going ex on Feb 13, 2024

Feb 14, 2024

Feb 28, 2024

Feb 13, 2024

Oct 26, 2023

KVUE.NB Final Cash Dividend of gross USD 0.2 paid on Nov 22, 2023 going ex on Nov 07, 2023

Nov 08, 2023

Nov 22, 2023

Nov 07, 2023

Jul 20, 2023

KVUE.NB Interim Cash Dividend of gross USD 0.2 paid on Sep 07, 2023 going ex on Aug 25, 2023

Aug 28, 2023

Sep 07, 2023

Aug 25, 2023

División de acciones

Fecha

Tipo

Relación

Sin datos

Fecha

Tipo

Relación

Sin datos

KeyAI



Kenvue Inc

21.509USD

Kenvue Inc

21.509

Descripción general

Compañía